Berlin, Berlin, Germany In 2010 was created Peppermint Venture Partners, which is appeared as VC. The leading representative office of defined VC is situated in the Berlin. The fund was located in Europe if to be more exact in Germany.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Peppermint Venture Partners, startups are often financed by High-Tech Gru00fcnderfonds, NRW.BANK, KfW. The meaningful sponsors for the fund in investment in the same round are High-Tech Gru00fcnderfonds, NRW.BANK, KfW. In the next rounds fund is usually obtained by High-Tech Gru00fcnderfonds, NRW.BANK, Meusinvest.
We can highlight the next thriving fund investment areas, such as Biopharma, Medical Device. Among the various public portfolio startups of the fund, we may underline Miracor Medical, Implandata Ophthalmic Products, Humedics Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. The fund has specific favorite in a number of founders of portfolio startups.
The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this VC is 9 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2016. The common things for fund are deals in the range of 5 - 10 millions dollars.
The fund was created by Klaus Stoeckemann. We also calculated 3 valuable employees in our database.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CryoTherapeutics | $11M | 02 Apr 2024 | Potsdam, Brandenburg, Germany | ||
Labforward | $5M | 08 Jan 2021 | Berlin, Berlin, Germany | ||
CryoTherapeutics | $8M | 27 Jun 2019 | Potsdam, Brandenburg, Germany | ||
Implandata Ophthalmic Products | 14 May 2018 | Hanover, Lower Saxony, Germany | |||
Miracor Medical | $8M | 25 Oct 2016 | Belgium, Liège, Belgium | ||
CryoTherapeutics | $6M | 07 Jul 2016 | Potsdam, Brandenburg, Germany | ||
Emperra | $3M | 04 Jan 2016 | Germany, Brandenburg | ||
Humedics | $7M | 10 Nov 2014 | Germany, Berlin | ||
Implandata Ophthalmic Products | $3M | 27 Oct 2014 | Hanover, Lower Saxony, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CryoTherapeutics | $11M | 02 Apr 2024 | Potsdam, Brandenburg, Germany | ||
Labforward | $5M | 08 Jan 2021 | Berlin, Berlin, Germany | ||
CryoTherapeutics | $8M | 27 Jun 2019 | Potsdam, Brandenburg, Germany | ||
Implandata Ophthalmic Products | 14 May 2018 | Hanover, Lower Saxony, Germany | |||
Miracor Medical | $8M | 25 Oct 2016 | Belgium, Liège, Belgium | ||
CryoTherapeutics | $6M | 07 Jul 2016 | Potsdam, Brandenburg, Germany | ||
Emperra | $3M | 04 Jan 2016 | Germany, Brandenburg | ||
Humedics | $7M | 10 Nov 2014 | Germany, Berlin | ||
Implandata Ophthalmic Products | $3M | 27 Oct 2014 | Hanover, Lower Saxony, Germany |
